Soluble E-cadherin is a valid prognostic marker in gastric carcinoma

Gut

Volumn 48, Issue 6, 2001, Pages 808-811

  Chan, A O O ^a   Lam, S K ^a   Chu, K M ^a   Lam, C M ^a   Kwok, E ^a   Leung, S Y ^a   Yuen, S T ^a   Law, S Y K ^a   Hui, W M ^a   Lai, K C ^a   Wong, C Y ^a   Hu, H C ^a   Lai, C L ^a   Wong, J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

E cadherin; Gastric cancer; Tumour marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MONOCLONAL ANTIBODY; TUMOR MARKER; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER RISK; CANCER STAGING; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES, MONOCLONAL; CADHERINS; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DISCRIMINANT ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NORMAL DISTRIBUTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035018890     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.6.808     Document Type: Article

References (36)

1. 1 Food, nutrition and the prevention of cancer: A global perspective. Washington, DC: World Cancer Research Fund and American Institute for Cancer Research, 1997:150.
2. 2 Behrens J, Mareel MM, Van Roy FM, et al. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989;108:2435-47.
3. 3 Frixen UH, Behrens J, Sachs M, Eberle G, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-85.
4. 4 Vleminckx K, Vakaet L. Jr, Mareel M, et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66:107-19.
5. 5 Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-11.
6. 6 Griffiths TR, Brotherick I, Bishop RI, et al. Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence, Br J Cancer 1996; 74:579-84.
7. 7 Velikova G, Banks RE, Gearing A, et al. Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer 1998;77:1857-63.
8. 8 Velikova G, Banks RE, Gearing A, et al. Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer. Br J Cancer 1997;76:1398-404.
9. 9 Gofuku J, Shiozaki H, Doki Y, et al. Characterization of soluble E-cadherin as a disease marker in gastric cancer patients. Br J Cancer 1998;78:1095-101.
10. 10 Nishi M, Omori Y, Miwa K, eds. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. Tokyo: Kanehara, 1995.
11. 11 Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
12. 12 Katayama M, Hirai S, Kamihagi K, et al. Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 1994;69:580-5.
13. 13 Shimoyama Y, Hirohashi S. Expression of E-and P-cadherin in gastric carcinomas. Cancer Res 1991;51: 2185-92.
14. 14 Mayer B, Johnson JP, Leitl F, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993;53:1690-5.
15. 15 Dorudi S, Sheffield JP, Poulsom R, et al. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 1993;142:981-6.
16. 16 Gagliardi G, Kandemir O, Liu D, et al. Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virthows Arch 1995;426:149-54.
17. 17 Pignatelli M, Ansari TW, Gunter P, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 1994;174:243-8.
18. 18 Jankowski JA, Newham PM, Kandemir O, et al. Differential expression of E-cadherin in normal, metaplastic and dysplastic oesophageal mucosa: a putative biomarker. Int J Oncol 1994;4:441-8.
19. 19 Kozyraki R, Scoazec JY, Flejou JF, et al. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver. Gastroenterology 1996;110:1137-49.
20. 20 Umbas R, Isaacs WB, Bringuier PP, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994;54:3929-33.
21. 21 Bringuier PP, Umbas R, Schaafsma HE, et al. Decreased E-cadherin immunoreactiviry correlates with poor survival in patients with bladder tumors. Cancer Res 1993;53:3241-5.
22. 22 Syrigos KN, Krausz T, Waxman J, et al. E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer 1995;64:367-70.
23. 23 Moll R, Mitze M, Frixen UH, et al. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993;143:1731-42.
24. 24 Siitonen SM, Kononen JT, Helin HJ, et al. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 1996;105:394-402.
25. 25 Andrews NA, Jones AS, Helliwell TR, et al. Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 1997;75:1474-80.
26. 26 Becker KF, Atkinson MJ, Reich U, et al. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hunt Mol Genet 1993;2:803-4.
27. 27 Gabbert HE, Mueller W, Schneiders A, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 1996;69:184-9.
28. 28 Wheelock MJ, Buck CA, Bechtol KB, et al. Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem 1987;34:187-202.
29. 29 Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 1988;102: 639-55.
30. 30 Furukawa F, Fujii K, Horiguchi Y, et al. Roles of E-and P-cadherin in the human skin. Microsc Res Tech 1997;38: 343-52.
31. 31 Shirahama S, Furukawa F, Wakita H, et al. E-and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer. J Dermatol Sci 1996;13:30-6.
32. 32 Matsuyoshi N, Tanaka T, Toda K, et al. Soluble E-cadherin: a novel cutaneous disease marker. Br J Dermatol 1995;132: 745-9.
33. 33 Pittard AJ, Banks RE, Galley HF, et al. Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome. Br J Anaesth 1996;76:629-31.
34. 34 Livingstone JI, Yasui W, Tahara E, et al. Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study. Br J Cancer 1995;72:976-80.
35. 35 Adachi Y, Oshiro T, Mori M, et al. Tumour size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol 1997;4:137-40.
36. 36 Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochem Biophys Acta 1994; 1198:11-26.